 NEW YORK, Sept. 28, 2021 PRNewswire -- Q BioMed Inc. OTCQB: QBIO a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, has seen an uptick in Strontium89 Strontium Chloride Sr-89 Injection, USP sales starting its 4th Quarter. 